Is probenecid's addition beneficial in tigecycline therapy?

What makes adding probenecid to tigecycline therapy interesting?

Probenecid blocks renal tubular secretion of many drugs, raising their blood levels and prolonging half-life. For tigecycline, this property prompted early research into whether the combination could lower the required dose or improve exposure.

Does probenecid raise tigecycline levels?

Studies show that co-administration with probenecid increases tigecycline's AUC by about 20 % and its Cmax by roughly 10 %. The effect is modest and does not warrant routine clinical use.

Why do labs still explore the idea?

Researchers continue to test the pairing in pharmacokinetics labs because tigecycline's high cost and occasional supply shortages make any pharmacokinetic improvement attractive. The 20 % exposure gain remains far below the 75–100 % verdoppelung needed to justify a clinical trial.

How does it compare to other dose-sparing approaches?

Other strategies—such as front-loading regimens, extended infusions, or targeting higher MIC breakpoints—currently yield larger and more reliable pharmacokinetic improvements.